Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Clinical Evidence for Targeting NAD Therapeutically
Studies show improvements in cholesterol levels, triglycerides, and inflammatory markers
Detection windows are not publicly established with precision, but peptide metabolites can persist for days to weeks depending on testing sensitivity
(2001) preclinical study (PMID 11285201) demonstrating that the C-terminal fragment of hGH (residues 177-191, the basis of AOD-9604) inhibits fat cell formation in 3T3-L1 cells, establishing the rationale for AOD-9604 as a lipolytic agent
A basic spreadsheet or notebook tracking: daily dose and time, weekly weight, bi-weekly measurements, and subjective notes provides sufficient data without excessive burden
.png)
